Andrea Varga

6.6k citations
76 papers · 4.2k · 3 hit papers · h-index 27

Impact in

  • Oncology top 1%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
    • Pancreatic and Hepatic Oncology Research
  • Immunology top 5%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction

Papers in

    • Cancer Immunotherapy and Biomarkers 19
    • HER2/EGFR in Cancer Research 7
    • Colorectal Cancer Treatments and Studies 7
    • Lung Cancer Treatments and Mutations 12
    • Advanced Breast Cancer Therapies 6

Andrea Varga

75 papers receiving 4.1k citations

Andrea Varga's Hit Papers

Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE ‐158 and KEYNOTE ‐028 studies 2020 · 385 citations
3850+3+6Years since publication100200300400500

Peers

Andrea Varga
Comparison fields: 5 of 101
  • Oncology 2.1k
  • Immunology 561
  • Pulmonary and Respiratory Medicine 708
  • Cancer Research 323
  • Obstetrics and Gynecology 160
Replace Giovanni Fucà with:
Giovanni Fucà Italy
Stefano Tamberi Italy
Erica Michelle Stringer-Reasor United States
Thomas A. Puchalski United States
Seong Hyeon Yun South Korea
Jean-Pascal Machiels Belgium
Irina Linkov United States
Sally E. Baron-Hay Australia
Hendrik‐Tobias Arkenau United Kingdom
Andrea Varga relative to Giovanni Fucà Italy Giovanni Fucà's profile →
Citations per field
00.5×20×40×68×
Giovanni Fucà · 1×
Citations per year

Countries citing papers authored by Andrea Varga

Since Specialization
Citations

This map shows the geographic impact of Andrea Varga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Varga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Varga more than expected).

Fields of papers citing papers by Andrea Varga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Varga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Varga. The network helps show where Andrea Varga may publish in the future.

Co-authors

The 25 scholars most cited alongside Andrea Varga, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrea Varga Line = papers co-authored together Andrea Varga links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study
Hit paper breakdown →
2018512
2
Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1–Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 Trial
Hit paper breakdown →
2017437
3
Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE ‐158 and KEYNOTE ‐028 studies
Hit paper breakdown →
2020385
4 2019309
5 2018297
6 2018225
7 2017170
8 2019165
9 2018163
10 2018117
11 2018105
12 201390
13 201685
14 202074
15 201971
16 201769
17 202066
18 201363
19 201862
20 202054

About Andrea Varga

Andrea Varga is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Pathology and Forensic Medicine and Molecular Biology, having authored 76 papers that have together received 4.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (19 papers), Cancer Genomics and Diagnostics (12 papers), Lung Cancer Treatments and Mutations (12 papers), HER2/EGFR in Cancer Research (7 papers), Colorectal Cancer Treatments and Studies (7 papers), Advanced Breast Cancer Therapies (6 papers), Lymphoma Diagnosis and Treatment (5 papers) and Fibroblast Growth Factor Research (4 papers). The work is most often cited by research in Oncology (2.1k citations), Immunology (561 citations), Pulmonary and Respiratory Medicine (708 citations), Cancer Research (323 citations) and Obstetrics and Gynecology (160 citations). Andrea Varga has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Sarina Anne Piha-Paul, Jean‐Charles Soria, Patrick Alexander Ott, Hope S. Rugo, Sanatan Saraf, Jean‐Marie Michot, Antoine Hollebecque, Christophe Le Tourneau, Christophe Massard and Vincent Ribrag. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, Investigational New Drugs, Clinical Cancer Research and Anti-Cancer Drugs.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact